EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

FAS and FASL expression in autoimmune lymphoproliferative syndrome and immune thrombocytopenia: limited diagnostic utility as transcriptional biomarkers

Paola Montanari, Federico Rondot, Anna Pau, Anna Clemente, Cristina Calvi, Ilaria Galliano iD, Stefano Gambarino, Massimiliano Bergallo

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-12950-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Paola Montanari und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Public Health and Pediatric Sciences, Medical School, Immunopathology Laboratory, University of Turin, Turin, 10126, Italy. Hauptthemen laut MEDLINE: Autoimmune Lymphoproliferative Syndrome, Fas Ligand Protein, fas Receptor, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autoimmune lymphoproliferative syndrome (ALPS) is an immune dysregulation disorder caused by defective lymphocyte apoptosis, most commonly involving the FAS–FAS ligand pathway. Because ALPS frequently presents with autoimmune cytopenias, particularly immune thrombocytopenia (ITP), its diagnosis may be challenging. This study evaluated whether FAS and FAS ligand gene expression could distinguish ALPS from ITP.

Methods

FAS and FAS ligand messenger RNA expression was measured by quantitative real-time polymerase chain reaction in whole-blood samples from patients with pediatric-onset ALPS ( n = 24), patients with chronic ITP ( n = 27), and healthy controls ( n = 22). Expression levels were compared among groups, and their diagnostic performance was assessed using receiver operating characteristic curve analysis.

Results

FAS expression was significantly higher in patients with ALPS than in healthy controls ( p < 0.01), but no significant difference was observed between ALPS and ITP. FAS expression showed moderate discrimination between ALPS and healthy controls but poor discrimination between ALPS and ITP. FAS ligand expression did not differ significantly among groups and showed no meaningful diagnostic performance. Neither FAS nor FAS ligand expression correlated with double-negative T-cell percentages or differed according to treatment status in patients with ALPS.

Conclusions

FAS and FAS ligand transcriptional levels do not provide disease-specific discrimination between ALPS and ITP. These findings support the continued use of clinical, immunophenotypic, functional, and genetic investigations for the diagnosis of ALPS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Autoimmune Lymphoproliferative SyndromeFas Ligand Proteinfas ReceptorPurpura, Thrombocytopenic, IdiopathicHumansFemaleMaleChildBiomarkersChild, PreschoolAdolescentCase-Control StudiesROC CurveRNA, MessengerApoptosis

Stichwörter der Autor:innen

ApoptosisAutoimmune lymphoproliferative syndromeBiomarkersFASFAS ligandImmune thrombocytopenia

Substanzen

Fas Ligand Proteinfas ReceptorFAS protein, humanFASLG protein, humanBiomarkersRNA, Messenger

Autor:innen und Institutionen

  • Department of Public Health and Pediatric Sciences, Medical School, Immunopathology Laboratory, University of Turin, Turin, 10126, Italy.
  • Laboratory of Specialistic Pediatry, Department of Children's Disease and Care, Regina Margherita Children Hospital, Turin, 10126, Italy.
  • Department of Molecular Biotechnology and Health Sciences, University of Turin, Turin, 10126, Italy.
  • Department of Public Health and Pediatric Sciences, Medical School, Immunopathology Laboratory, University of Turin, Turin, 10126, Italy. ilaria.galliano@unito.it.
  • Laboratory of Specialistic Pediatry, Department of Children's Disease and Care, Regina Margherita Children Hospital, Turin, 10126, Italy. ilaria.galliano@unito.it.

ORCID-Profile: Ilaria Galliano

Zitieren

APA

Montanari, P., Rondot, F., Pau, A., Clemente, A., Calvi, C., Galliano, I., Gambarino, S., & Bergallo, M. (2026). FAS and FASL expression in autoimmune lymphoproliferative syndrome and immune thrombocytopenia: limited diagnostic utility as transcriptional biomarkers. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12950-0

Vancouver

Montanari P, Rondot F, Pau A, Clemente A, Calvi C, Galliano I, et al. FAS and FASL expression in autoimmune lymphoproliferative syndrome and immune thrombocytopenia: limited diagnostic utility as transcriptional biomarkers. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12950-0

BibTeX
@article{Montanari2026,
  author = {Montanari, Paola and Rondot, Federico and Pau, Anna and Clemente, Anna and Calvi, Cristina and Galliano, Ilaria and Gambarino, Stefano and Bergallo, Massimiliano},
  title = {FAS and FASL expression in autoimmune lymphoproliferative syndrome and immune thrombocytopenia: limited diagnostic utility as transcriptional biomarkers},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-12950-0}
}
Kostenlos starten →